首页> 外国专利> Gene expression signature as a predictor of chemotherapeutic response in breast cancer

Gene expression signature as a predictor of chemotherapeutic response in breast cancer

机译:基因表达签名可预测乳腺癌化疗反应

摘要

Disclosed are methods and compositions for determining and/or predicting a response to a therapy, especially a cancer therapy, including chemotherapy. Specifically, the disclosure provides profiles of a set of marker genes in breast cancers from patients who were known to have responded or not responded to a chemotherapy for predicting response to the same therapy including different combination of chemotherapy in a patient diagnosed with breast cancer. The disclosure further provides computer complemented methods for the prediction based on genetic profiles as well as different clinical parameters. Furthermore, the disclosure provides kits for performing the method disclosed.
机译:公开了用于确定和/或预测对疗法,特别是癌症疗法,包括化学疗法的反应的方法和组合物。具体地,本公开提供了来自已知对化学疗法有反应或没有化学疗法的患者的乳腺癌中的一组标记基因的概况,以预测对诊断为乳腺癌的患者的对相同疗法的反应,包括化学疗法的不同组合。本公开进一步提供了用于基于遗传概况以及不同临床参数进行预测的计算机补充方法。此外,本公开提供了用于执行所公开的方法的试剂盒。

著录项

  • 公开/公告号IL223383A

    专利类型

  • 公开/公告日2019-03-31

    原文格式PDF

  • 申请/专利权人 BIOARRAY GENETICS INC.;

    申请/专利号IL20120223383

  • 发明设计人

    申请日2012-12-02

  • 分类号C12Q1/68;

  • 国家 IL

  • 入库时间 2022-08-21 12:02:16

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号